New Medical Devices research report from GlobalData is now available from Fast Market Research

Boston, MA -- (SBWire) -- 06/05/2014 --Luminex Corporation (Luminex) is a medical devices company. The company develops, manufactures and markets its proprietary biological testing technologies. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. It operates its business through two reportable business segments, namely, the Technology and Strategic Partnerships (TSP) segment and the Assays and Related Products (ARP) segment. Its TRP segment's product portfolio consists of Luminex LX 100/200, FLEXMAP 3D and MAGPIX; xPONENT, MicroPlex microspheres, MagPlex microspheres, xTAG microspheres, SeroMAP microspheres, and calibration and control microspheres. The ARP segment comprises assay products including respiratory viral family, gastrointestinal pathogen detection family, MultiCode assays and products family, among others. Luminex offers its product and services in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

View Full Report Details and Table of Contents

The company focuses on strengthening its alliances with its partners, as recently, it entered into a collaboration and license agreement with Merck for the development of a companion diagnostic device.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Luminex Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Luminex Corporation (LMNX) - Financial and Strategic SWOT Analysis Review
- Corgenix Medical Corporation (CONX) - Product Pipeline Analysis, 2014 Update
- Volcano Corporation (VOLC) - Product Pipeline Analysis, 2014 Update
- Exact Sciences Corporation (EXAS) - Product Pipeline Analysis, 2014 Update
- Cordis Corporation - Product Pipeline Analysis, 2014 Update
- Analogic Corporation (ALOG) - Product Pipeline Analysis, 2014 Update
- MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts
- MediPoint: Neurovascular Interventions - US Analysis and Market Forecasts
- PositiveID Corporation (PSID) - Product Pipeline Analysis, 2013 Update
- MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts